益生元原料市场－全球产业规模、份额、趋势、机会及预测（按类型、来源、应用、细菌活性、功能、地区和竞争格局划分），2021-2031年

全球益生元成分市场预计将从 2025 年的 74.6 亿美元成长到 2031 年的 126.2 亿美元，复合年增长率为 9.16%。

该市场涵盖宿主微生物利用的非消化性化合物，这些化合物能够带来健康益处并增强功能。推动这一增长的关键因素是预防性医疗保健的普及以及人们对微生物组对整体健康影响（尤其是在免疫功能和肠脑轴方面）的科学认识不断加深。这些基本驱动因素支撑着市场需求，製造商正越来越多地将益生元纤维添加到膳食补充剂、饮料和机能性食品中，以满足注重健康的消费者的需求。

然而，该行业面临着许多挑战，包括监管的不确定性以及需要严格的科学检验来支持新的健康声明。标籤标准和定义的区域差异可能会造成消费者困惑，并阻碍国际贸易。全球益生元协会于2024年对1972名消费者进行的一项调查发现，心理健康是益生元使用者最关注的两大健康议题之一。这项发现凸显了提供可靠的临床证据来检验消费者不断变化的需求并维护长期市场信誉的必要性。

市场驱动因素

消费者对微生物组健康和肠道健康的日益关注，正成为市场成长的主要催化剂，并显着改变他们的购买习惯。消化系统健康与更广泛的系统性益处（例如心理健康和免疫力）之间的关联日益紧密，推动着人们从被动治疗转向预防性营养方法。这项转变得到了强有力的科学检验，增强了消费者对益生元成分的信任，并鼓励将其纳入日常饮食中。例如，Krasad Biosciences 在 2025 年 11 月发布的报告《回顾 2025：Krasad 的进步之年》中指出，其专有的益生元得到了 125 多篇科学论文的支持，凸显了推动这一趋势的广泛研究。不断扩大的证据基础也与消费者赋权相契合。根据 Nuffoods Spectrum Asia 2025 年 2 月发表的一篇文章《健康还是钱包？ 》报导引用了一项调查结果，该调查显示，近七成消费者认为“健康食品是掌控自己未来健康的一种方式”，这支持了益生元的采用与对自身健康的掌控感之间的联繫。

对强化饮料和机能性食品日益增长的需求是第二个关键驱动因素，它推动益生元从利基补充剂市场走向主流零售市场。饮料生产商尤其利用益生元纤维来改良果汁和汽水配方，打造低糖、有益肠道健康的饮品，进而吸引年轻消费者。这种广泛的应用吸引了大量投资，为品牌快速扩张并进入大型零售商通路奠定了基础。根据《Inc.》杂誌2025年2月一篇题为「Ollipop完成5000万美元资金筹措后估值达18.5亿美元」的报导报道，益生元汽水公司Ollipop完成了5000万美元的C轮资金筹措，用于进一步拓展分销渠道和产品开发。这笔资金的涌入显示了益生元强化产品的商业性潜力，并激励原料供应商进行创新，以提高这些新剂型中的溶解度和稳定性，确保功能性应用的发展速度超过传统给药系统。

市场挑战

缺乏明确的监管规定和严格的科学论证要求，严重阻碍了全球益生元原料市场的扩张。生产商被迫在碎片化的环境中运营，不同司法管辖区的标籤标准和定义相互衝突，这不仅阻碍了国际贸易，也增加了遵循成本。这种监管的不确定性常常导致产品上市延迟，迫使企业投入大量资金来满足各地不同的要求，而非专注于创新。因此，高昂的检验成本将小规模企业拒之门外，降低了市场的多样性和竞争程度。

此外，能否获得监管部门核准所需的临床结果存在不确定性，这构成了重大的财务风险。 2024年，全球益生元协会报告称，在一项对临床干预措施的系统性回顾中，55.6%的益生元研究显示，与对照组相比，益生元对生长结果有显着影响。这项数据凸显了达到证据标准的固有难度。由于近一半的研究可能无法提供监管机构要求的结论性数据，企业在建立市场信誉所需的大量研发投资方面面临回报不确定性。

市场趋势

随着宠物越来越“拟人化”，饲主也越来越将伴侣动物视为家庭成员，认为它们应该获得预防性医疗保健。这促使动物用药品和高端宠物食品中益生元成分的添加成为变革性的趋势。这种观点加速了猫狗饮食中肠道健康解决方案的普及，其关注不再局限于简单的消化，而是扩展到延长寿命和增强免疫力。製造商正积极响应这项需求，开发富含优质益生元纤维（例如甜菜浆和菊苣根）的高端湿粮和干粮，以此作为功能性宣称的基础。根据美国宠物用品协会 (APPA) 于 2025 年 6 月发布的《2025 年犬猫报告》，2024 年功能性犬粮（含有益生菌和益生元）的销量同比增长 18%，凸显了消费者对高附加价值营养的快速需求增长。

同时，市场对使用果寡糖和菊糖改善产品质地和减少糖分的需求日益增长。主要原料供应商正利用这些纤维在维持产品质地的同时，满足严格的健康法规要求。除了作为甜味剂外，这些益生元成分还因其能够在改良产品中重现脂肪和糖的口感而备受青睐，从而解决了「更健康」领域的一项关键技术难题。这种双重效用正推动能够提供洁净标示解决方案的製造商实现显着的收入成长。例如，泰莱公司在2025年5月公布，截至2025年3月的财年，其新产品销售额年增9%。该公司将这一业绩主要归功于市场对其减糖平台和膳食纤维的强劲需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球益生元原料市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（寡糖、聚葡萄糖、菊糖、其他）
  • 依成分分类（根茎类、谷类、蔬菜、其他）
  • 按应用领域（食品和饮料、动物饲料、营养补充品）
  • 透过细菌活动（双歧桿菌、乳酸菌等）
  • 功能性（肠道健康、骨骼健康、心血管健康、体重管理、免疫功能）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美益生元原料市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲益生元原料市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区益生元原料市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲益生元原料市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美益生元原料市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球益生元原料市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Cargill Incorporated
• BENEO GmbH
• Ingredion Incorporated
• Friesland Campina Ingredients
• Tate & Lyle PLC
• Kerry Group plc
• Yakult Honsha Co., Ltd.
• Roquette Freres SA
• Nexira SAS
• Cosucra Groupe Warcoing SA

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Prebiotics Ingredients Market is projected to expand from USD 7.46 Billion in 2025 to USD 12.62 Billion by 2031, reflecting a compound annual growth rate of 9.16%. This market encompasses non-digestible compounds that host microorganisms utilize to generate health or performance advantages. The primary catalysts for this growth are a broad transition toward preventive healthcare and a more profound scientific appreciation of the microbiome's influence on systemic well-being, specifically regarding immune function and the gut-brain axis. These fundamental drivers sustain market demand as manufacturers increasingly integrate prebiotic fibers into dietary supplements, beverages, and functional foods to satisfy health-conscious consumers.

However, the industry encounters significant hurdles regarding regulatory ambiguity and the necessity for strict scientific verification to back emerging health claims. Discrepancies in labeling standards and definitions across different regions can confuse consumers and impede international commerce. According to a 2024 survey by the 'Global Prebiotic Association' involving 1,972 consumers, mental health was identified as one of the top two reported health concerns among users of prebiotics. This finding underscores the essential requirement for solid clinical evidence to validate these shifting consumer priorities and maintain the market's long-term credibility.

Market Driver

Rising consumer awareness regarding microbiome wellness and gut health acts as a major catalyst for market growth, significantly reshaping purchasing habits. Individuals are increasingly associating digestive health with wider systemic advantages, including mental well-being and immunity, prompting a move from reactive treatments toward proactive nutritional approaches. This transition is underpinned by substantial scientific validation, which fosters trust in prebiotic ingredients and promotes their inclusion in daily diets. For example, Clasado Biosciences noted in their November 2025 report, '2025 in review: Clasado reflects on a year of progress,' that their proprietary prebiotic is supported by over 125 scientific publications, highlighting the extensive research driving this movement. This expanding evidence base aligns with consumer empowerment; a February 2025 article in Nuffoods Spectrum Asia titled 'Wellness or the Wallet?' cited a survey where nearly seven out of ten consumers agreed that healthy foods provide control over their future health, confirming the connection between prebiotic adoption and perceived ownership of personal wellness.

The growing demand for fortified beverages and functional foods represents a second crucial driver, extending the presence of prebiotics from niche supplements into mainstream retail sectors. Beverage producers are specifically utilizing prebiotic fibers to reformulate juices and sodas, creating low-sugar, gut-friendly options that resonate with younger consumers. This versatility in application draws substantial investment, allowing brands to rapidly scale and gain placement in major retail outlets. As reported by Inc. Magazine in February 2025, in the article 'Olipop Valued at $1.85 Billion Valuation After $50 Million Fundraise', the prebiotic soda company Olipop closed a $50-million Series C funding round to boost distribution and product development. Such capital inflows demonstrate the commercial potential of prebiotic-fortified products, prompting ingredient suppliers to innovate for better solubility and stability in these new formats, ensuring functional applications grow faster than traditional delivery systems.

Market Challenge

The absence of clear regulations and the strict demand for scientific proof pose a major obstacle to the expansion of the Global Prebiotics Ingredients Market. Producers are forced to operate within a fragmented environment characterized by conflicting labeling standards and definitions across different jurisdictions, which hampers global trade and raises compliance expenses. This regulatory uncertainty frequently postpones product introductions and compels companies to direct significant funds toward satisfying varied regional mandates rather than focusing on innovation. Consequently, the high expense associated with validating claims excludes smaller entities, thereby diminishing overall market diversity and competition.

Moreover, the uncertainty surrounding the acquisition of clinical results required for regulatory approval introduces substantial financial risk. In '2024', the 'Global Prebiotic Association' reported that a systematic review of clinical interventions indicated that 55.6 percent of prebiotic studies showed significant effects on growth outcomes compared to control groups. This statistic emphasizes the inherent difficulties in satisfying evidentiary benchmarks; with nearly half of such studies potentially failing to produce the definitive data regulators demand, companies confront uncertain returns on the extensive research investments necessary to build market credibility.

Market Trends

The incorporation of prebiotic ingredients into animal health and premium pet nutrition is developing as a transformative trend, fueled by the "humanization" of pets, where owners increasingly view companion animals as family members deserving of preventative healthcare. This perspective has accelerated the inclusion of gut-health solutions in feline and canine diets, extending beyond simple digestion to address longevity and immune support. Manufacturers are addressing this demand by creating premium wet foods and kibble enriched with high-quality prebiotic fibers, such as beet pulp and chicory root, to support functional claims. According to the American Pet Products Association's June 2025 'Dog & Cat Report 2025', purchasing data indicated that functional pet diets containing probiotics and prebiotics increased by 18 percent for dogs in 2024, highlighting the swift consumer shift toward value-added nutrition.

Concurrently, the use of oligofructose and inulin for texture enhancement and sugar reduction is growing as major ingredient suppliers utilize these fibers to comply with strict health regulations without sacrificing sensory quality. Beyond their role as sweeteners, these prebiotic ingredients are valued for their capacity to replicate the mouthfeel of fat and sugar in reformulated items, solving a key technical hurdle in the "better-for-you" segment. This dual utility is generating substantial revenue growth for manufacturers capable of providing clean-label solutions. For instance, Tate & Lyle reported in May 2025, within their 'Final Results for the year ended 31 March 2025', that the company's New Product revenue rose by 9 percent on a like-for-like basis, a result largely credited to strong demand for their sugar reduction platforms and dietary fibers.

Key Market Players

• Cargill Incorporated
• BENEO GmbH
• Ingredion Incorporated
• Friesland Campina Ingredients
• Tate & Lyle PLC
• Kerry Group plc
• Yakult Honsha Co., Ltd.
• Roquette Freres S.A.
• Nexira SAS
• Cosucra Groupe Warcoing S.A.

Report Scope

In this report, the Global Prebiotics Ingredients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Prebiotics Ingredients Market, By Type

• Oligosaccharides
• Polydextrose
• Inulin and Others

Prebiotics Ingredients Market, By Source

• Roots
• Grains
• Vegetables and Others

Prebiotics Ingredients Market, By Application

• Food & Beverages
• Animal Feed and Dietary Supplements

Prebiotics Ingredients Market, By Bacterial Activity

• Bifidobacterial
• Lactic Acid Bacteria and Others

Prebiotics Ingredients Market, By Functionality

• Gut Health
• Bone Health
• Cardiovascular Health
• Weight Management and Immunity

Prebiotics Ingredients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Prebiotics Ingredients Market.

Available Customizations:

Global Prebiotics Ingredients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Prebiotics Ingredients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Oligosaccharides, Polydextrose, Inulin and Others)
  • 5.2.2. By Source (Roots, Grains, Vegetables and Others)
  • 5.2.3. By Application (Food & Beverages, Animal Feed and Dietary Supplements)
  • 5.2.4. By Bacterial Activity (Bifidobacterial, Lactic Acid Bacteria and Others)
  • 5.2.5. By Functionality (Gut Health, Bone Health, Cardiovascular Health, Weight Management and Immunity)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Prebiotics Ingredients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Source
  • 6.2.3. By Application
  • 6.2.4. By Bacterial Activity
  • 6.2.5. By Functionality
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Prebiotics Ingredients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Source
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Bacterial Activity
      • 6.3.1.2.5. By Functionality
  • 6.3.2. Canada Prebiotics Ingredients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Source
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Bacterial Activity
      • 6.3.2.2.5. By Functionality
  • 6.3.3. Mexico Prebiotics Ingredients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Source
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Bacterial Activity
      • 6.3.3.2.5. By Functionality

7. Europe Prebiotics Ingredients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Source
  • 7.2.3. By Application
  • 7.2.4. By Bacterial Activity
  • 7.2.5. By Functionality
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Prebiotics Ingredients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Source
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Bacterial Activity
      • 7.3.1.2.5. By Functionality
  • 7.3.2. France Prebiotics Ingredients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Source
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Bacterial Activity
      • 7.3.2.2.5. By Functionality
  • 7.3.3. United Kingdom Prebiotics Ingredients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Source
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Bacterial Activity
      • 7.3.3.2.5. By Functionality
  • 7.3.4. Italy Prebiotics Ingredients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Source
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Bacterial Activity
      • 7.3.4.2.5. By Functionality
  • 7.3.5. Spain Prebiotics Ingredients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Source
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Bacterial Activity
      • 7.3.5.2.5. By Functionality

8. Asia Pacific Prebiotics Ingredients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Source
  • 8.2.3. By Application
  • 8.2.4. By Bacterial Activity
  • 8.2.5. By Functionality
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Prebiotics Ingredients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Source
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Bacterial Activity
      • 8.3.1.2.5. By Functionality
  • 8.3.2. India Prebiotics Ingredients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Source
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Bacterial Activity
      • 8.3.2.2.5. By Functionality
  • 8.3.3. Japan Prebiotics Ingredients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Source
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Bacterial Activity
      • 8.3.3.2.5. By Functionality
  • 8.3.4. South Korea Prebiotics Ingredients Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Source
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Bacterial Activity
      • 8.3.4.2.5. By Functionality
  • 8.3.5. Australia Prebiotics Ingredients Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Source
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Bacterial Activity
      • 8.3.5.2.5. By Functionality

9. Middle East & Africa Prebiotics Ingredients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Source
  • 9.2.3. By Application
  • 9.2.4. By Bacterial Activity
  • 9.2.5. By Functionality
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Prebiotics Ingredients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Source
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Bacterial Activity
      • 9.3.1.2.5. By Functionality
  • 9.3.2. UAE Prebiotics Ingredients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Source
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Bacterial Activity
      • 9.3.2.2.5. By Functionality
  • 9.3.3. South Africa Prebiotics Ingredients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Source
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Bacterial Activity
      • 9.3.3.2.5. By Functionality

10. South America Prebiotics Ingredients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Source
  • 10.2.3. By Application
  • 10.2.4. By Bacterial Activity
  • 10.2.5. By Functionality
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Prebiotics Ingredients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Source
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Bacterial Activity
      • 10.3.1.2.5. By Functionality
  • 10.3.2. Colombia Prebiotics Ingredients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Source
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Bacterial Activity
      • 10.3.2.2.5. By Functionality
  • 10.3.3. Argentina Prebiotics Ingredients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Source
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Bacterial Activity
      • 10.3.3.2.5. By Functionality

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Prebiotics Ingredients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cargill Incorporated
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. BENEO GmbH
• 15.3. Ingredion Incorporated
• 15.4. Friesland Campina Ingredients
• 15.5. Tate & Lyle PLC
• 15.6. Kerry Group plc
• 15.7. Yakult Honsha Co., Ltd.
• 15.8. Roquette Freres S.A.
• 15.9. Nexira SAS
• 15.10. Cosucra Groupe Warcoing S.A.

16. Strategic Recommendations

17. About Us & Disclaimer